TURN THERAPEUTICS
LIVE

Serial Number

88044977

Owner

GLOBAL HEALTH SOLUTIONS, INC.

Attorney

Todd M. Malynn

First Use Date

Jul 31, 2019

Filing Date

Jul 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TURN THERAPEUTICS Trademark

Serial Number: 88044977 • Registration: 6283602

TURN THERAPEUTICS is a trademark filed by GLOBAL HEALTH SOLUTIONS, INC. on July 19, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GLOBAL HEALTH SOLUTIONS, INC. (6 trademarks)

ROME, GA 30165

Entity Type: 03

Global Health Solutions LLC (9 trademarks)

Rome, GA 30165

Entity Type: 16

Trademark Details

Filing Date

July 19, 2018

Registration Date

March 2, 2021

First Use Anywhere

July 31, 2019

First Use in Commerce

July 31, 2019

Published for Opposition

November 13, 2018

Goods & Services

Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for infectious diseases; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ocular pharmaceuticals; Plant extracts for pharmaceutical purposes

Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing of pharmaceuticals

Filing History

OFFICE ACTION ISSUED POU1
May 20, 2026 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 20, 2026 APRE
TEAS SECTION 8 RECEIVED
Apr 24, 2026 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 2, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 2, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 28, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 27, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 27, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 25, 2021 AITU
USE AMENDMENT FILED
Jan 6, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 6, 2021 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 2, 2020 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2020 EXRA
SOU EXTENSION 3 GRANTED
Jul 8, 2020 EX3G
SOU EXTENSION 3 FILED
Jul 8, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 8, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2020 EXRA
SOU EXTENSION 2 GRANTED
Jan 2, 2020 EX2G
SOU EXTENSION 2 FILED
Jan 2, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 2, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2019 EXRA
SOU EXTENSION 1 GRANTED
Jul 5, 2019 EX1G
SOU EXTENSION 1 FILED
Jul 5, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 5, 2019 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 29, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 29, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 8, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 24, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 9, 2018 PREV
ASSIGNED TO LIE
Oct 8, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 22, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 22, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 22, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 22, 2018 CNEA
ASSIGNED TO EXAMINER
Sep 21, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2018 NWOS
NEW APPLICATION ENTERED
Jul 23, 2018 NWAP